Insights

Market Leadership PARI is the global market leader in nebuliser devices for cystic fibrosis, offering extensive opportunities to engage healthcare providers and medical institutions specializing in respiratory conditions.

Product Innovation With a focus on innovative inhalation solutions and eFlow technology, PARI presents opportunities to introduce advanced respiratory therapy products to hospitals, clinics, and pharmaceutical partners looking to enhance their treatment offerings.

Strategic Expansion The company's international presence and broad distribution network indicate potential sales avenues across multiple regions, especially in markets prioritizing respiratory health and medical device adoption.

Technology Stack PARI's use of modern technology like SAP, Kotlin, and Amazon S3 suggests efficient operations and digital engagement channels, facilitating targeted outreach to medical professionals and distribution partners.

Financial Capacity With revenue between $50 million and $100 million, PARI is positioned for growth and investing in new product development, creating opportunities for sales collaborations around their respiratory care portfolio and expand their market share.

Similar companies to PARI

PARI Tech Stack

PARI uses 8 technology products and services including C3.js, Amazon S3, SAP, and more. Explore PARI's tech stack below.

  • C3.js
    Charting
  • Amazon S3
    Content Delivery Network
  • SAP
    Customer Relationship Management
  • SAP ERP
    Enterprise Resource Planning
  • Modernizr
    Javascript Libraries
  • Office 365
    Office Suites
  • Kotlin
    Programming Languages
  • Gemini
    Testing And Qa

Media & News

PARI's Email Address Formats

PARI uses at least 2 format(s):
PARI Email FormatsExamplePercentage
F.Last@pari.deJ.Doe@pari.de
88%
F_Last@pari.deJ_Doe@pari.de
7%
First.Last@pari.deJohn.Doe@pari.de
5%
First.Last@pari.comJohn.Doe@pari.com
87%
FLast@pari.comJDoe@pari.com
10%
First@pari.comJohn@pari.com
1%
FirstL@pari.comJohnD@pari.com
2%

Frequently Asked Questions

What is PARI's stock symbol?

Minus sign iconPlus sign icon
PARI is a publicly traded company; the company's stock symbol is PABU.

What is PARI's official website and social media links?

Minus sign iconPlus sign icon
PARI's official website is pari.com and has social profiles on LinkedIn.

How much revenue does PARI generate?

Minus sign iconPlus sign icon
As of December 2025, PARI's annual revenue is estimated to be $13M.

What is PARI's SIC code NAICS code?

Minus sign iconPlus sign icon
PARI's SIC code is 3841 - Surgical and Medical Instruments and Apparatus NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does PARI have currently?

Minus sign iconPlus sign icon
As of December 2025, PARI has approximately 501 employees across 6 continents, including EuropeAsiaNorth America. Key team members include Vp Sales Europe & Asia Pacific: G. B.President Pari Pharma Gmbh: M. H.President & Executive Officer, Pari Japan Gk: H. T.. Explore PARI's employee directory with LeadIQ.

What industry does PARI belong to?

Minus sign iconPlus sign icon
PARI operates in the Medical Equipment Manufacturing industry.

What technology does PARI use?

Minus sign iconPlus sign icon
PARI's tech stack includes C3.jsAmazon S3SAPSAP ERPModernizrOffice 365KotlinGemini.

What is PARI's email format?

Minus sign iconPlus sign icon
PARI's email format typically follows the pattern of F.Last@pari.de. Find more PARI email formats with LeadIQ.

When was PARI founded?

Minus sign iconPlus sign icon
PARI was founded in 1906.

PARI

Medical Equipment ManufacturingBavaria, Germany501-1000 Employees

PARI was founded in Wuppertal in 1906 and has progressed during its more than 100 years of company history from a small manufacturer to a globally respected specialist in respiratory therapy. At present, the PARI business group is headquartered in Starnberg, Germany with additional locations in Weilheim, Germany (PARItec, production) and Gräfelfing, Germany (PARI Pharma, medicinal products and eFlow technology). In addition, there are international branch offices and a worldwide distribution network.
As a manufacturer of medical devices with a focus on respiratory therapy, PARI has been the brand to trust for doctors, pharmacists and patients, for many decades. Continuous development and steady growth enabled PARI to expand their market leadership in Germany for equipment, saline solutions and respiratory aids. PARI is the global market leader in the field of nebuliser devices for cystic fibrosis.  
PARI offers specially optimized devices and solutions for inhalation for pulmonary, bronchial and also nasopharyngeal diseases. A broad portfolio is used to provide patients with comprehensive care, ranging from diagnosis and treatment to monitoring. PARI’s mission is to improve the lives of those affected by respiratory diseases and those who provide care to them. In addition to innovative products and tailored solutions, PARI also offers comprehensive services for users, medical professionals and distribution partners. 
Are you seeking new career opportunities? Visit our website www.pari.com and find out more about open positions.

Section iconCompany Overview

Website
pari.com
SIC Code
3841 - Surgical and Medical Instruments and Apparatus
Stock Symbol
PABU
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
1906
Employees
501-1000

Section iconFunding & Financials

  • $50M$100M

    PARI's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    PARI's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.